Do small, voluntary community hospitals face separate issues and need different services from pharmaceutical sales representatives than their large, for-profit counterparts?
Do small, voluntary community hospitals face separate issues and need different services from pharmaceutical sales representatives than their large, for-profit counterparts?
This question was raised by Janis Belcher, an executive professional sales rep with McNeil Pharmaceutical and a subscriber to Pharmaceutical Representative. To answer her question, we contacted Harold Hunter, professor and director of health care administration program at California State University of Long Beach (CA).
Pharmaceutical Representative: How has the health care environment changed for voluntary community hospitals in recent years?
HUNTER: Many of these hospitals used to operate with charitable donations, but a lot of their sources have dried up. Starting with World War II, Catholic and inner-city hospitals have lost their middle class clientele, who used to pay the bills, because of flight from the inner cities to the suburbs. This left hospitals in much poorer areas and treating very different conditions and different patients than they ever did before.
Most people are insured through their workplace or through Medicaid, or they aren't insured at all. Until recently, Medicaid didn't pay very well, so what hospitals used to do was take in the Medicaid patients and charge the insured patients a little more. That was called "cost-shifting." But now insurance companies don't want to pay more.
Pharmaceutical Representative: What are the top two issues facing voluntary community hospitals today?
HUNTER: For small voluntary community hospitals, the major issue is payment. The second issue is the different demographic mix. The patient population is younger and faces a higher birth rate, more violence and more trauma. There is a greater tendency for hospitals to have ups and downs in terms of occupancy. There are also a lot of foreign medical graduates because American doctors prefer not to work in places like south Chicago. These hospitals are safety net providers who help those no one else will help. They are always financially distressed and, quite often, need to reach into the community.
Pharmaceutical Representative: What challenges do these issues pose for sales reps?
HUNTER: The challenges are going into bad neighborhoods and understanding what their particular problems are. Some hospitals may have three or four managed care companies, each of which has its own formulary. The hospital may not have control over the managed care companies' formulary, but they have to stock the drugs that comply with all the formularies. Any kind of contribution of drugs, such as pediatric medicines, would certainly be appreciated and helpful.
A rep should go touch base with the hospital administrator, the chief of medical staff and the hospital pharmacist to get a sense of where the hospital is going. PR
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.